doi: 10.3892/mmr.2015.4377
Sikirica MV, Martin AA, Wood R, Leith A, Piercy J, Higgins V
(The answer is none.) A provider who acknowledges the limitations while explaining their rationale for prescribing is more trustworthy than one who overpromises
Mass Spectrometry (MS) Data: The COA must include mass spectrometry (MS) confirmation to verify the compounds exact molecular weight, confirming its chemical identity
Trial results at the 48 week mark are expected by 4Q 2023
In contrast, ACSL3 (acyl-CoA synthetase long chain family member 3)-mediated metabolism of MUFAs (monounsaturated fatty acids) can inhibit ferroptosis, possibly due to its structural differences from PUFAs [7, 99,100,101] (Fig